DRIO (DRIO) Stock Price & Analysis
DRIO (DRIO) fell 5.13% to USD 6.87 as of September 8, 2026 at 17:55 UTC, according to Nexqual real-time market data.
DRIO last closed at USD 6.87; the session ranged USD 6.87–7.25 on volume of 7,341 shares. Market capitalization is —, with a 52-week range of USD 5.85–17.74 (NCM). Source: Nexqual, September 8, 2026 at 17:55 UTC.
Key Statistics (as of September 8, 2026 at 17:55 UTC)
| Price | USD 6.87 |
|---|---|
| Change | ▼ 5.13% (down) |
| Previous Close | USD 6.87 |
| Open | USD 6.87 |
| Day Range | USD 6.87 – 7.25 |
| 52-Week Range | USD 5.85 – 17.74 |
| Volume | 7,341 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DRIO)
Nexqual's technical model rates DRIO "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 17:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.42 (neutral) |
| vs SMA50 | Below (USD 7.18) |
| MACD | -0.06 (negative) |
From DRIO's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PAVM | PAVmed Inc. | USD 4.83 | ▼ 5.21% |
| CLPT | ClearPoint Neuro Inc. | USD 13.64 | ▼ 2.92% |
| MYO | Myomo Inc. | USD 1.36 | ▼ 2.86% |
| CTSO | Cytosorbents Corporation | USD 6.75 | ▼ 3.6% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.24 | ▼ 8.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:55 UTC. This page is informational and not investment advice.